A Paradoxical Role for Myeloid-Derived Suppressor Cells in Sepsis and Trauma

Bronte V. (2009) Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions. Eur. J. Immunol. 39:2670–2.

Gabrilovich DI, Nagaraj S. (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9:162–74.

Ostrand-Rosenberg S, Sinha P. (2009) Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182:4499–506.

Murphey ED, et al. (2004) Diminished bacterial clearance is associated with decreased IL-12 and interferon-gamma production but a sustained proinflammatory response in a murine model of postseptic immunosuppression. Shock. 21:415–25.

Young MR, Newby M, Wepsic HT. (1987) Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. Cancer Res. 47:100–5.

Peranzoni E, et al. (2010) Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 22:238–44.

Nagaraj S, et al. (2009) Regulatory myeloid suppressor cells in health and disease. Cancer Res. 69:7503–6.

Kusmartsev S, Gabrilovich DI. (2005) STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J. Immunol. 174:4880–91.

Gallina G, et al. (2006) Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J. Clin. Invest. 116:2777–90.

Angulo I, et al. (2000) Nitric oxide-producing CD11b(+)Ly-6G(Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosup-pressed mice. Blood. 95:212–20.

Rossner S, et al. (2005) Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro. Eur. J. Immunol. 35:3533–44.

Delano MJ, et al. (2007) MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204:1463–74.

Movahedi K, et al. (2008) Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood. 111:4233–44.

Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. (2008) Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181:5791–802.

Zea AH, et al. (2005) Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 65:3044–8.

Filipazzi P, et al. (2007) Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J. Clin. Oncol. 25:2546–53.

Ochoa AC, Zea AH, Hernandez C, Rodriguez PC. (2007) Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin. Cancer Res. 13:721s–6s.

Rodriguez PC, et al. (2009) Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 69:1553–60.

Nagaraj S, Gabrilovich DI. (2007) Myeloid-derived suppressor cells. Adv. Exp. Med. Biol. 601:213–23.

Corzo CA, et al. (2009) Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J. Immunol. 182(9):5693–701.

Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI. (2004) Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J. Immunol. 172:989–99.

Popovic PJ, Zeh HJ 3rd, Ochoa JB. (2007) Arginine and immunity. J.Nutr. 137:1681S–6S.

Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V. (2008) Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol. Rev. 222:162–79.

Bronte V, Zanovello P. (2005) Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 5:641–54.

Nagaraj S, et al. (2007) Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat. Med. 13(7):828–35.

Bunt SK, Sinha P, Clements VK, Leips J, Ostrand Rosenberg S. (2006) Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J. Immunol. 176(1):284–90.

Pande K, et al. (2009) Cancer-induced expansion and activation of CD11b+ Gr-1+ cells predispose mice to adenoviral-triggered anaphylactoid-type reactions. Mol. Ther. 17:508–15.

Sander LE, et al. (2010) Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207:1453–64.

Noel G, et al. (2007) Postburn monocytes are the major producers of TNF-alpha in the heterogeneous splenic macrophage population. Shock. 27:312–9.

Noel G, et al. (2010) A ribonucleotide reductase inhibitor reverses burn induced inflammatory defects. Shock. 34:535–44.

Noel JG, et al. (2005) Effect of thermal injury on splenic myelopoiesis. Shock. 23:115–22.

Noel JG, et al. (2007) Thermal injury elevates the inflammatory monocyte subpopulation in multiple compartments. Shock. 28:684–93.

Eruslanov E, Daurkin I, Ortiz J, Vieweg J, Kusmartsev S. (2010) Pivotal advance: tumormediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE2 catabolism in myeloid cells. J. Leukoc. Biol. 88:839–48.

Vuk-Pavlovic S, et al. (2010) Immunosuppressive CD14+HLA-DRlow/-monocytes in prostate cancer. Prostate. 70:443–55.

Cheng P, et al. (2008) Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J. Exp. Med. 205:2235–49.

Ueda Y, Cain DW, Kuraoka M, Kondo M, Kelsoe G. (2009) IL-1R type I-dependent hemopoietic stem cell proliferation is necessary for inflammatory granulopoiesis and reactive neutrophilia. J. Immunol. 182:6477–84.

Ueda Y, Kondo M, Kelsoe G. (2005) Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J. Exp. Med. 201(11):1771–80.

Fearon DT, Locksley RM. (1996) The instructive role of innate immunity in the acquired immune response. Science. 272:50–3.

Scumpia PO, et al. (2010) Cutting edge: bacterial infection induces hematopoietic stem and progenitor cell expansion in the absence of TLR signaling. J. Immunol. 184:2247–51.

Kusmartsev S, et al. (2003) All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Res. 63:4441–9.

Kusmartsev S, et al. (2008) Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma. Clin. Cancer Res. 14:8270–8.

Greifenberg V, Ribechini E, Rossner S, Lutz MB. (2009) Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development. Eur. J. Immunol. 39:2865–76.

Fricke I, et al. (2007) Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses. Clin Cancer Res. 13:4840–8.

Gabrilovich D, et al. (1998) Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood. 92:4150–66.

Khan SY, et al. (2006) Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood. 108:2455–62.

Ozao-Choy J, et al. (2009) The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. Cancer Res. 69:2514–22.

Laudanski K, De A, Miller-Graziano C. (2007) Exogenous heat shock protein 27 uniquely blocks differentiation of monocytes to dendritic cells. Eur. J. Immunol. 37:2812–24.

Makarenkova VP, Bansal V, Matta BM, Perez LA, Ochoa JB. (2006) CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J. Immunol. 176:2085–94.

Scumpia PO, et al. (2007) Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood. 110:3673–81.

Scumpia PO, et al. (2005) CD11c+ dendritic cells are required for survival in murine polymicrobial sepsis. J. Immunol. 175:3282–6.

Opal SM, et al. (1999) Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gramnegative sepsis. Blood. 93:3467–72.

Hotchkiss RS, et al. (1999) Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med. 27:1230–51.

Bakker AB, Baker E, Sutherland GR, Phillips JH, Lanier LL. (1999) Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc. Nat. Acad. Sci. U. S. A. 96:9792–6.

Joyce-Shaikh B, et al. (2010) Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis. J. Exp. Med. 207:579–89.

Pan PY, et al. (2008) Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function. Blood. 111:219–28.

Zhu B, et al. (2007) CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J. Immunol. 179:5228–37.

Gabrilovich DI, Velders MP, Sotomayor EM, Kast WM. (2001) Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J. Immunol. 166:5398–406.

Sinha P, Clements VK, Ostrand-Rosenberg S. (2005) Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J. Immunol. 174:636–45.

Dolcetti L, et al. (2010) Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 40:22–35.

Huang B, et al. (2006) Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66:1123–31.

Umemura N, et al. (2008) Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1-and M2-type characteristics. Journal of leukocyte biology. 83:1136–44.

Pan PY, et al. (2010) Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res. 70(1):99–108.

Zhou Z, et al. (2010) Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells. Stem Cells. 28:620–32.